Johnson & Johnson to buy Shockwave Medical for US$12.5 billion
Johnson & Johnson will buy medical device maker Shockwave Medical for about US$12.5 billion, the companies said on Friday (Apr 5), helping the healthcare conglomerate boost its portfolio of medical devices.
The California-based company makes a device which uses shockwaves to break down calcified plaque in heart vessels, similar to how kidney stones are treated.
Under the deal, J&J would pay US$335 per share in cash for the medical device maker. The offer price implies a 4.7% premium to Shockwave’s last close of US$319.99 on Thursday.
Shockwave, a company that makes devices to treat heart disease, has a market capitalisation of about US$12 billion, according to LSEG data. REUTERS
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Nelson Loh intends to plead guilty to charges including forgery and cheating
Singapore shares edge up at Friday’s open; STI up 0.2%
Data leak reveals links between money laundering accused Su Jianfeng and sale of Dubai properties
‘No better player’ than GIC to help revitalise fortunes of Singapore stock market: observers
Businessmen in Singapore placed on China’s wanted list weeks after money laundering raid in 2023
Stocks to watch: NetLink NBN Trust, Centurion, No Signboard